TC Biopharm (NASDAQ:TCBP) Trading Down 55.8% – Here’s Why

TC Biopharm (Holdings) Plc (NASDAQ:TCBP)’s stock price dropped 55.8% during mid-day trading on Wednesday . The stock traded as low as $0.50 and last traded at $0.68. Approximately 5,325,030 shares changed hands during mid-day trading, an increase of 3,145% from the average daily volume of 164,101 shares. The stock had previously closed at $1.54.

TC Biopharm Trading Down 55.8%

The firm has a fifty day simple moving average of $0.68 and a 200 day simple moving average of $3.04.

TC Biopharm Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.